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1. Introduction
  
 The escalation of worldwide infection cases caused 
by antibiotic-resistant bacteria presents a serious 
challenge to the health of global population (Levy and 
Marshall 2004; Gelband et al. 2015). An example of 
such pathogenic bacteria is Staphylococcus aureus (WHO 
2017), especially the strain so called Methicillin-resistant 
S. aureus (MRSA) (Hassoun et al. 2017). Current guideline 
in the treatment of S. aureus infection primarily relies on 
the application of first-line β-lactam antibiotics, such as 
selected penicillin and cephalosporins derivatives, and 
in the MRSA-related infections, vancomycin remains the 
first-choice arsenal to be used in the treatment (Tong 
et al. 2015). Unfortunately, the increasing number of S. 
aureus strains that are resistant to available antibiotics 
has been widely reported (Tong et al. 2015; Hassoun 
et al. 2017; WHO 2017), critically emphasizes the need 
to discover new antibacterial agents that are effective 
to treat the pathogenic mutant strains of S. aureus.    
 At present, directed exploration of natural resources 
is the main pathway to discover new entities of 
antibacterial agents with a possible novel mode of 
action (Lewis 2013; Wright 2014). Of many potential 
sources to find antibacterial compounds with such 
characteristics, roselle (Hibiscus sabdariffa L.) calyx 
is perhaps one of great choices. Roselle calyx extract 
has been reported to exert antistaphylococcal activity 
both in vitro (Liu et al. 2005; Alaga et al. 2014) and in 
vivo (Ahsan et al. 2019). With such promising results 
in hand, it seems sensible to advance research into 
the next level: step-by-step assessment on the nature 
of antibacterial compound(s) contained in the roselle 
calyx extract.
 In effort to discover new antibacterial agent(s) 
from natural resources, the use of inexpensive and 
practical in vivo model organism become an important 
subject to consider. In accordance with that, we 
recently demonstrated the use of fruit fly or vinegar fly 
(Drosophila melanogaster) infection model to assess the 
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anti-staphylococcal activity of crude extracts prepared 
from green algae Ulva reticulata (Nainu et al. 2018) 
and roselle (Hibiscus sabdariffa L.) calyx (Ahsan et al. 
2019). While it is evident that the fruit fly model of 
infection is easy-to-use and suitable for rapid in vivo 
screening, this particular insect has been reported as 
a suitable host for Staphylococcus aureus (Needham 
et al. 2004; Garcia-Lara et al. 2005; Wu et al. 2012; 
Nainu et al. 2018). In addition, the application of cost-
effective yet robust techniques available in fruit fly has 
been central attention to the promising use of such 
model system in developing countries with limited 
access to advanced research facilities. Taking those 
advantages into account, here we presented the in vivo 
anti-staphylococcal activity of fractions prepared from 
ethanolic extract of roselle (H. sabdariffa L.) calyx using 
our established Drosophila infection model.
2. Materials and Methods
2.1. Bacterial Strains and Fly Stocks
Bacterial infection experiments were carried out 
using a 24-h old culture of S. aureus ATCC 29213 
(collection of microbiology laboratory, Faculty of 
Pharmacy, Hasanuddin University). The bacterial 
inoculum was collected, washed carefully with 
phosphate buffered saline (PBS), diluted equal to 0.5 
McFarland density, and suspended in PBS prior to use. 
The following lines of D. melanogaster were used as in 
vivo model organisms: w1118 as wildtype (background) 
control and psh[1];;modSP[KO] as the immunodeficient 
fly line with diminished activity of Toll pathway. Both 
fly lines were subjected to standard maintenance in 
cornmeal-agar medium at 25°C.
 
2.2. Preparation of Roselle Extract and Fractions
Roselle (Hibiscus sabdariffa L.) calyces were collected 
from Makassar, South Sulawesi, Indonesia and processed 
in a wet and dry sortation methods. Dried samples were 
subsequently subjected to a maceration procedure using 
70% ethanol for 1 x 24 hours and then re-macerated for 1 
x 24 hours, as described in (Ahsan et al. 2019) with slight 
modifications. All resulting filtrates were pooled and 
processed in a rotary evaporator to produce extract with 
proper thickness. The resulting extract was subsequently 
subjected to the fractionation process using water: 
ethyl acetate mixture (1:1). Ethanolic extract of roselle 
calyces and its fractionated preparations were freeze-
dried and used as samples in this study.
2.3. Fly Infection, Survival Assay and Bacterial 
Growth Analysis 
Infection experiment was performed on the thorax 
of male D. melanogaster by using the pricking method, 
as described previously (Nainu et al. 2018; Ahsan et al. 
2019; Nainu et al. 2019). Briefly, 4-7 days old of adult 
male fruit flies (30 flies per group of treatment) were 
pricked using a tungsten fine needle that had been 
previously dipped in the S. aureus culture (100-fold 
dilution of 0.5 McFarland density). All pricked flies were 
maintained at 29°C and subjected to either assessment 
on fly survivorship or bacterial growth analysis using 
colony-forming assay as described previously (Nainu 
et al. 2018; Ahsan et al. 2019; Nainu et al. 2019). In the 
assessment of fly survival during infection, S. aureus-
pricked flies were maintained in the presence or absence 
of roselle fractions or 200 µg/ml tetracycline as positive 
control and the number of survived/dead flies in each 
group was recorded twice in a day during the course 
of the experiment. For the assessment of bacterial 
growth during infection, S. aureus-pricked flies were 
maintained in a similar fashion as in the fly survival assay 
and at a designated time, five live flies were collected 
and manually squashed in PBS solution using a micro 
pestle to produce a fly lysate. Homogenates prepared 
from each group were serially diluted and cultured on 
Vogel-Johnson agar medium at 37°C for 1 x 24 hours. 
The number of bacterial colonies found on the Vogel-
Johnson agar plate after incubation is expressed as 
CFU/ml. In all fly survival and colony-forming assay 
experiments, groups of PBS-pricked flies were used 
as controls.
2.4. In vitro Assessment on Cell Viability and 
Immunostimulation Potency
Cell viability and immunostimulation potency were 
assessed using cell-based reporter assay system, as 
described previously (Kanoh et al. 2015). Briefly, Drs-Luc-
DL1 Drosophila cell line was incubated in the presence 
of tested samples at six different concentrations starting 
from 0.1 ppm to 100 ppm. Drs-Luc-DL1 Drosophila cells 
were tested for the viability upon incubation with 
different samples’ concentrations for 12 hours at 25°C 
using CellTiter®-Glo Luminescent Cell Viability Assay 
(Promega) according to the manufacturer’s protocol. 
Using the same experimental layout, Drs-Luc-DL1 
Drosophila cells were examined for the Drosomycin 
stimulation potency using ONE-Glo Luciferase Assay 
System (Promega) according to the manufacturer’s 
protocol. 
2.5. Antimicrobial Peptide (AMP) Expression 
Analysis 
Analysis on the expression of Drosomycin, an 
endogenous antimicrobial peptide produced by 
Drosophila in response to Gram-positive bacterial 
infection, was carried out using total RNA prepared 
from five w1118 fly line in each experimental group at 
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50 hours post-inoculation with S. aureus. The collected 
Drosophila were homogenized in the Treff tube and 
subsequently processed using SV Total RNA Isolation 
System (Promega) as per manufacturer’s instruction. 
Assessment on the level of Drosomycin (Drs) was 
carried out based on the reverse transcriptase (RT)-
qPCR method using a pair of Drs primer. The sequence 
of Drs forward (F) and Drs reverse (R) were as follows: 
(Drs-F) 5’-CGTGAGAACCTTTTCCAATATGATG-3’ and 
(Drs-R) 5’-TCCCAGGACCACCAGCAT-3’. All RT-qPCR 
reactions were held in a 20 µl volume using GoTaq® 
1-Step RT-qPCR System (Promega), according to the 
manufacturer’s protocol. The following RT-qPCR 
profile was carried out in a Rotor-Gene Q thermal 
cycler (Qiagen, Germany): reverse transcription step 
at 37°C for 15 mins, denaturation step at 95°C for 10 
mins, and 40 cyclic repeats of 95°C for 10 secs and 
60°C for 30 secs, and final extension step at 72°C for 
30 secs. The expression level of host reference gene, 
ribosomal protein rp49, was assessed in each run using 
a pair of rp49 primer and using the same RT-qPCR 
protocol as above. The sequence of rp49 forward (F) 
primer and rp49 reverse (R) primer were as follows: 
(rp49-F) 5’-GACGCTTCAAGGGACAGTATCTG-3’ and 
(rp49-R) 5’-AAACGCGGTTCTGCATGAG-3’. The relative 
expression of Drs to rp49 was analyzed using qGENE 
software (version 2.0.3.2) and the result was further 
subjected to statistical analysis. To verify the specificity 
of primers used in our RT-qPCR experiments, standard 
melt curve analysis was performed in each run.
 
2.6. Data Processing, Graph Preparation, and 
Statistical Analysis
All data, obtained from at least three independent 
experiments, were statistically processed using 
GraphPad Prism® 8. Data on fly survivorship were 
constructed as a Kaplan-Meier graph and statistically 
analyzed using log-rank approach. Data on bacterial 
growth, cell viability, immune stimulation potency, and 
Drosomycin mRNA level were shown as bar graphs and 
subjected to statistical analysis using one-way ANOVA. 
All data presented in this study are shown as mean ± 
S.D and p values of less than 0.05 were considered as 
significant.
3. Results
3.1. Dose-dependent Toxicity of Roselle 
Fractions in Cell Culture and Adult of Drosophila 
melanogaster
 In this study, we investigated the antistaphylococcal 
effect of water and ethyl acetate fractions, or simply 
abbreviated as WFR and EAFR respectively, prepared 
from ethanolic extract of roselle calyx using our 
established Drosophila-based in vivo approach. As a 
start, we prepared WFR and EAFR from the ethanolic 
extract of roselle calyces and subsequently performed 
cell viability assay and fly survival assay to determine 
the toxicity as well as an appropriate concentration of 
WFR and EAFR to be used in the further experiments. 
As shown in Figure 1a, the viability of Drosophila 
cells was negatively affected by both samples at 
high concentrations (250 ppm) but not at the lower 
concentrations tested in the experiments. In accordance 
to that, the survival of adult male flies of w1118 (Figure 
1b) and psh[1];;modSP[KO] immunodeficient mutant 
line (Figure 1c) were not affected upon ingestion of 
either WFR or EAFR at concentrations up to 2% w/w. 
However, the survivals of both fly lines were adversely 
affected once maintained in foods containing each 
fractionated roselle samples at higher concentration 
(8% w/w). Results obtained from both in vitro and in 
vivo experiments clearly suggested the dose-dependent 
lethal effect of roselle fractions used in this study. To 
rule out such possible toxic influence, we used WFR 
and EAFR at a concentration ranging from 100 to 0.1 
ppm and at concentration of 0.5% and 2% (w/w) in 
further in vitro and in vivo experiments, respectively.
3.2. Augmentation of Host Survival Rate by 
Roselle Fractions During Bacterial Infection
 We previously reported the antibacterial activity 
of roselle calyx crude extract against Gram-positive 
S. aureus in D. melanogaster. However, the nature of 
the antibacterial compounds remains unidentified. To 
provide better insight, we carried out similar in vivo 
fly survival and CFU assays, in addition to an in vitro 
approach firstly performed in this study, using WFR and 
EAFR, fractions prepared from roselle calyx extract. We 
found that the survival of adult D. melanogaster w1118 was 
rapidly declined under S. aureus infection condition and 
such trend was subject for improvement by the use of 
either antibiotic (as positive control) or the crude extract 
of roselle calyx (5%). Treatments of S. aureus-infected 
w1118 with WFR or EAFR at a concentration of 2%, but 
not at 0.5%, were sufficient to reduce flies’ mortality 
(Figure 2a), suggesting the in vivo anti-staphylococcal 
action of roselle fractions, WFR and EAFR, at a suitable 
concentration. 
3.3. Inhibition of Bacterial Growth by Roselle 
Fractions
 Augmentation of flies’ mortality during S. aureus 
infection was reported to be linked with amplified 
bacterial load. Hence, the inhibition of bacterial 
proliferation, either by the use of antibiotics or 
crude plant extracts, has been shown to enhance the 
survivorship of infected Drosophila. With this in mind, 
308                                                                                                                                                             Nainu F et al.
HAYATI J Biosci                                                                                                                                                                     309











Healthy control Healthy control
Time (hours) Time (hours)
EER 5% EER 5%
WFR 0.5% WFR 0.5%
WFR 2% WFR 2%
WFR 8% WFR 8%
EAFR 0.5% EAFR 0.5%
EAFR 2% EAFR 2%
























































Figure 1. Dose-dependent toxicity of roselle fractions in Drosophila. (a) The incorporation of either WFR or EAFR in the 
cell media reduced the viability of Drs-Luc-DL1 cells in a concentration-dependent manner. (b and c) Similarly, 
ingestion of food-containing either WFR or EAFR decreased the survivorship of flies in a manner dependent on 
samples’ concentration. Adult 4-7 days old male w1118 (b) and psh[1];;modSP[KO] (c) were maintained at 25°C 
in fly food containing samples at three different concentrations (0.5, 2, and 8%). The number of survived and 
dead flies were recorded daily and fly survivorship was analysed using a Kaplan-Meier-Log Rank approach. EER: 
ethanolic extract of roselle calyx, WFR: water fractions of rosella calyx extract, EAFR: ethyl acetate fractions of 
rosella calyx extract
we carried out CFU assays to confirm whether protection 
seen in both WFR-treated and EAFR-treated S. aureus-
infected flies (Figure 2a) was the result of bacterial 
growth inhibition. Indeed, we noticed that continuous 
treatment of infected Drosophila with either 2% WFR 
or 2% EAFR was surely effective to reduce bacterial 
growth (Figure 2b), further maintaining the notion 
that inhibition of bacterial growth is vital in order to 
achieve improved host survivorship during infection.
3.4. Anti-Staphylococcal Activity of Roselle 
Fractions was Achieved Independent of 
Drosomycin Expression
 Drosophila expressed an array of antimicrobial 
peptides (AMPs), including the well-characterized 
Drosomycin, that plays an important role in the innate 
immune response against S. aureus. To determine 
the involvement of Drosomycin expression in the 
antibacterial activity of WFR and EAFR against S. aureus, 
prepared from adult w1118 flies. As shown in Figure 3b, 
Drosomycin (Drs) expression was considerably induced 
in response to S. aureus infection and a comparable level 
of gene expression was similarly observed in other fly 
groups: the control groups (tetracycline-treated or 5% 
roselle calyx extract-treated), WFR-treated, and EAFR-
treated S. aureus-infected fly groups. Moreover, level 
of Drs expression in all groups of treatments was not 
significantly different, clearly indicating that treatments 
given to the infected flies, either antibiotics, 5% roselle 
extract, 2% WFR, or 2% EAFR, did not increase the 
expression of Drs thus had no effect on the stimulation 
of Drs-related innate immune response in the S. aureus-
infected host.
3.5. Protective Effect of Roselle Fractions in the 
S. aureus-infected Immunodeficient Host
 Increased fly survivorship and reduced bacterial 
load were two trends observed in groups of S. aureus-
infected flies that were incubated in the presence of 
roselle fractions, WFR or EAFR. These two protection 
signatures were achieved by mechanisms independent 
of Drosomycin, one of the most important AMPs 
expressed by Drosophila in response to S. aureus 
infection. Therefore, we anticipated that the anti-
staphylococcal effect of WFR and EAFR might be 
resulted from the presence of selected antibacterial 
compounds available at a certain concentration in the 
roselle fractions tested in this study. To confirm this, 
we carried out pricking-based infection experiments 
on the psh[1];;modSP[KO], a fly line lacking for Psh and 
ModSP, two important components in the canonical 
Toll-mediated antibacterial immune response against 
S. aureus. As illustrated in Figure 4, the survival of 
psh[1];;modSP[KO] mutant flies was declined in a faster 
rate (Figure 4a) and infected immunodeficient mutant 
flies harbored slightly higher bacterial load (Figure 
4b) than its wild-type counterpart (Figure 2a and b, 
respectively), indicating the vital role of Psh and/or 
ModSP in the canonical Toll-mediated immune response 
against S. aureus infection. Nonetheless, it is important 
to note that two protection signatures: improvement 
of mutant flies’ survivorship (Figure 4a) and reduction 
of bacterial growth (Figure 4b) were evident in the 
groups of infected mutant flies upon treatment with 
either 2% WFR or 2% EAFR. Taken together, our results 
confirmed the in vivo anti-staphylococcal activity of 2% 
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Figure 2. Increased fly survivorship and impaired bacterial 
proliferation in infected flies given either WFR 
or EAFR. Adult 4-7 days old male w1118 were 
pricked with S. aureus and maintained at 25°C 
in food containing samples at two different 
concentrations (0.5 and 2%). These flies were 
subjected to survival assay (a) and analysis of 
bacterial growth (b). Groups of flies infected 
with S. aureus and maintained in the presence 
or absence of 200 µg/ml tetracycline were used 
as the negative and positive control groups, 
respectively. EER: ethanolic extract of roselle 
calyx, WFR: water fractions of rosella calyx 
extract, EAFR: ethyl acetate fractions of rosella 
calyx extract
we carried out two experimental approaches: in vitro 
and in vivo. In the in vitro experiment, we assessed Toll 
pathway-mediated Drosomycin expression by using 
cell-based reporter assay. We found that the expression 
of Drosomycin was not increased upon treatment with 
either WFR or EAFR (Figure 3a). In conjunction with 
the in vitro result, we also assessed the expression 
level of Drosomycin by RT-qPCR method using lysates 






































































EER 5% WFR 0.5%
WFR 0.5% EAFR 2%
WFR 2%
WFR 2% EAFR 2%Positive control
Positive control
Figure 3. Anti-staphylococcal protection of either WFR or 
EAFR was not due to stimulation in host humoral 
immunity. (a) Drs-Luc-DL1 cell line was treated 
with samples at different concentrations and 
subsequently assessed for its Drs level based on 
luciferase activity (p<0.001). (b) Adult 4-7 days 
old male w1118 were pricked with S. aureus and 
maintained at 25°C in food containing samples at 
given concentrations. These flies were subjected 
to total RNA isolation and subsequently followed 
by RT-qPCR for quantification of Drosomycin 
mRNA level. The expression level of rp49 was used 
as the reference control (p<0.001). EER: ethanolic 
extract of roselle calyx, WFR: water fractions of 
rosella calyx extract, EAFR: ethyl acetate fractions 
of rosella calyx extract Figure 4. Improved host survivorship and decreased bacterial growth in infected immunodeficient 
psh[1];;modSP[KO] flies in the presence 
of WFR or EAFR. Adult 4-7 days old male 
psh[1];;modSP[KO] flies were pricked with 
S. aureus and maintained at 25°C in food 
containing either water or ethyl acetate 
fractions of roselle extract. These flies were 
subsequently subjected to survival assay (a) and 
analysis of bacterial growth (b). Groups of flies 
infected with S. aureus and maintained in the 
presence or absence of 200 µg/ml tetracycline 
were used as the negative and positive control 
groups, respectively. EER: ethanolic extract of 
roselle calyx, WFR: water fractions of rosella 
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 Fruit fly D. melanogaster has been widely used to 
investigate cellular and molecular events that are 
relatively difficult to be addressed in higher model 
organisms (Pandey and Nichols 2011; Ugur et al. 
2016; Nainu et al. 2017; Rahmatika et al. 2019). In 
fact, in the last decade, low- to high-throughput 
drug discovery using D. melanogaster platform has 
been widely performed (Willoughby et al. 2013; 
Fernández-Hernández et al. 2016; Ekowati et al. 2017), 
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and interestingly, one drug (Vandetanib, ZD6474) was 
successfully approved by US FDA for the treatment of 
medullary thyroid carcinoma in 2011 (Das and Cagan 
2013).
 In this study, we examined the antibacterial effect 
of two roselle fractions, WFR and EAFR, against 
S. aureus using a simple yet robust in vitro and in 
vivo pharmacological approach based on the use of 
D. melanogaster. A major advantage of our in vivo 
approach is the applicability of several important 
assays that are time-consuming or difficult to be 
performed using vertebrate model organisms. 
In terms of infection experiment, some of the 
experimental features such as simplicity of host 
survival assessment during the course of infection, 
easiness to perform colony-forming assay or gene 
expression analysis using whole-body samples or 
in the particular sites of infected tissues, and more 
importantly, broad availability of various ready-
to-use lines of immunodeficient fruit flies, remain 
impressive powerful traits to be signified in Drosophila 
model of infection (Chamilos et al. 2011; Tzelepis et 
al. 2013).
 The antibacterial effect of roselle fractions, WFR 
and EAFR, against S. aureus infection in Drosophila is 
likely to be achieved independent from additional 
participation of canonical Toll-mediated innate 
immune response in the infected host, as suggested 
by results obtained from psh[1];;modSP[KO] fly line 
that was used as immunodeficient Drosophila model. 
In the absence of two important components of Toll 
pathway, Psh and ModSP, stimulation of humoral 
innate immunity in response to S. aureus infection in 
Drosophila (i.e. the expression of AMPs) are impaired 
thus leads to an immunodeficient-like state (Buchon 
et al. 2014). Flies with such state has been shown to 
succumb faster during pathogen challenge than their 
wild-type counterparts (El Chamy et al. 2008; Buchon 
et al. 2009). However, in our study, we demonstrated 
that ingestion of either WFR or EAFR could improve 
the survivorship of infected psh[1];;modSP[KO] fly 
line, suggesting the anti-staphylococcal nature of 
roselle fractions.
 Prior to infection experiments, we carried out 
toxicity assays using either cell cultures (in vitro) 
or adult flies (in vivo). Data obtained in these 
straightforward and time-effective assays suggested 
the toxicity of both roselle fractions was yielded in a 
manner dependent on the given dose of samples. Such 
results were important to decide the proper dose of 
roselle fractions to be used in the next experiments 
and to rule out the possible toxic effect of samples to 
host survival during infection experiments. 
 In this research, we extended our previous results 
to demonstrate the in vivo anti-staphylococcal effect 
of fractions prepared from ethanolic extract of roselle 
calyx using a Drosophila platform system. While our 
in vitro and in vivo results were in line, it is important 
to note that in vivo testing of drug candidate(s) could 
provide better insight than the in vitro results in terms 
of potential efficacy as well as possible harmful effect 
of drug candidate(s) to individuals, especially in the 
case where the tested compound(s) are pro-drug. 
Hence, the use of inexpensive in vivo model organism, 
such as D. melanogaster (Pandey and Nichols 2011), 
that bids a high chance for getting similar outcomes 
in the clinical trial on human subjects could be 
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